Status:

COMPLETED

InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study

Lead Sponsor:

MedtronicNeuro

Conditions:

Overactive Bladder

Urinary Urge Incontinence

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Post-market clinical follow-up for continued assessment of safety and performance of the InterStim basic evaluation lead and foramen needle(s) used during a therapy evaluation.

Eligibility Criteria

Inclusion

  • Subjects 18 years of age or older
  • Candidate for sacral neuromodulation in accordance with the InterStim System labeling
  • Have a diagnosis of overactive bladder (OAB) as demonstrated by either urinary urge incontinence and/or urinary frequency on a 3-day voiding diary
  • Willing and able to accurately complete study diaries, questionnaire, attend visits, and comply with the study protocol
  • Willing and able to provide signed and dated informed consent

Exclusion

  • Have neurological conditions such as multiple sclerosis, clinically significant peripheral neuropathy or spinal cord injury (e.g., paraplegia)
  • Have implantable pacemakers, or defibrillators
  • Have primary stress incontinence or mixed incontinence where the stress component overrides the urge component
  • Have knowledge of planned MRIs, diathermy, microwave exposure, high output ultrasonic exposure, or radio frequency (RF) energy exposure not included within the scanning conditions provided with the InterStim System labeling
  • Women who are pregnant or planning to become pregnant during participation in the study
  • Characteristics indicating a poor understanding of the study or characteristics that indicate the subject may have poor compliance with the study protocol requirements
  • Concurrent participation in another clinical study that may add additional safety risks and/or confound study results.

Key Trial Info

Start Date :

November 28 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 9 2020

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT04016324

Start Date

November 28 2019

End Date

October 9 2020

Last Update

November 23 2021

Active Locations (15)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (15 locations)

1

Pinellas Urology

St. Petersburg, Florida, United States, 33710

2

Florida Urology Partners

Tampa, Florida, United States, 33606

3

Minnesota Urology (Plymouth)

Plymouth, Minnesota, United States, 55441

4

Urologic Research and Consulting

Englewood, New Jersey, United States, 07631